GO:0045892 negative regulation of DNA-templated transcription: Repressor Networks, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045892 describes any process that stops, prevents, or reduces the frequency, rate, or extent of cellular DNA-templated transcription.
• Transcriptional repression is a core regulatory layer controlling cell identity, proliferation, and stress responses.
• Key repressor proteins include transcription factors, chromatin modifiers, and co-repressor complexes that alter histone marks and DNA accessibility.
• Dysregulation of negative regulation of DNA-templated transcription is linked to cancer, developmental disorders, and metabolic disease.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of repressor gene function.
• Transcriptomic and epigenomic methods such as RNA-seq, ChIP-seq, and ATAC-seq are used to map repression networks.
Description
Negative regulation of DNA-templated transcription (GO:0045892) is a biological process that reduces or prevents the initiation or elongation of RNA synthesis from a DNA template. This process is essential for maintaining appropriate gene expression programs during development, differentiation, and homeostasis. It involves a diverse set of transcription factors, chromatin-modifying enzymes, and co-repressor complexes that collectively silence or dampen target genes. Researchers study this process to understand how cells control gene dosage, respond to environmental signals, and prevent aberrant activation of oncogenes or developmental pathways. Disruption of transcriptional repression is increasingly recognized as a driver of human disease, including breast cancer and other malignancies. Computational analyses of repressor gene variants, such as those in HIC1, further highlight the importance of these regulatory mechanisms in disease susceptibility.
negative regulation of DNA-templated transcription At A Glance
| GO ID | GO:0045892 |
|---|---|
| GO term | negative regulation of DNA-templated transcription |
| Ontology | biological_process |
| Synonym | transcription repressor activity; downregulation of transcription, DNA-dependent; inhibition of gene-specific transcription |
| Major function | Reduces or prevents RNA synthesis from DNA templates, controlling gene expression programs |
| Key molecular players | Transcription factors, co-repressors, histone deacetylases, methyltransferases, chromatin remodelers |
| Associated processes | Cell differentiation, development, oncogenesis, stress response, metabolism |
| Research methods | RNA-seq, ChIP-seq, ATAC-seq, CRISPR screens, reporter assays |
What Is GO:0045892?
GO:0045892 encompasses any cellular process that stops, prevents, or reduces the frequency, rate, or extent of DNA-templated transcription. This includes direct inhibition of RNA polymerase activity, recruitment of co-repressors, chromatin compaction, and post-translational modification of histones that render promoters inaccessible. The term covers both gene-specific repression and global transcriptional downregulation.
Why Is negative regulation of DNA-templated transcription Important in Cell Biology?
Negative regulation of DNA-templated transcription is fundamental to cellular decision-making, ensuring that genes are expressed at the right time, place, and level. Its dysregulation contributes to cancer, developmental disorders, and immune dysfunction, making it a prime target for therapeutic intervention and a focus of CRISPR-based functional genomics.
• Controls cell fate decisions during development and differentiation.
• Prevents inappropriate activation of oncogenes and developmental pathways.
• Maintains tissue-specific gene expression patterns.
• Mediates responses to stress and metabolic signals.
• Involved in X-chromosome inactivation and genomic imprinting.
• Dysregulated in breast cancer and other malignancies.
• Targeted by epigenetic drugs such as HDAC inhibitors.
• Essential for immune cell function and inflammation control.
• Provides a mechanism for feedback inhibition in signaling pathways.
• Offers opportunities for CRISPR-based therapeutic editing.
What Happens During negative regulation of DNA-templated transcription?
Recognition of target genes by repressor proteins
In simple terms: Repressor proteins find and bind to specific DNA sequences near genes they want to silence.
Sequence-specific transcription factors recognize promoter or enhancer elements and recruit co-repressor complexes. For example, HIC1 binds to consensus sequences and recruits HDAC complexes to repress target genes. This step is critical for gene-specific repression and is often disrupted by mutations in DNA-binding domains.
Recruitment of co-repressor complexes
In simple terms: Once bound, repressors bring in helper proteins that modify chromatin and block transcription.
Co-repressors such as N-CoR, SMRT, and Sin3A are recruited to DNA-bound repressors and serve as scaffolds for histone-modifying enzymes. These complexes include histone deacetylases (HDACs) and histone methyltransferases that establish repressive chromatin marks.
Chromatin modification and compaction
In simple terms: Chemical tags are added to histones, causing DNA to pack tightly and become inaccessible.
HDACs remove acetyl groups from histone lysines, while methyltransferases add methyl groups to H3K9 and H3K27, creating binding sites for heterochromatin proteins. Negatively charged histone acylations can also alter nucleosome dynamics and stability. These modifications lead to chromatin compaction and reduced accessibility for RNA polymerase.
Inhibition of RNA polymerase II initiation and elongation
In simple terms: The transcription machinery is blocked from starting or continuing RNA synthesis.
Repressive chromatin prevents recruitment of RNA polymerase II and general transcription factors. Additionally, some repressors directly inhibit elongation by recruiting negative elongation factors. This dual control ensures robust silencing of target genes.
Maintenance and heritability of repression
In simple terms: The silenced state can be passed on to daughter cells during division.
Epigenetic marks such as DNA methylation and histone modifications are maintained through cell divisions by enzymes like DNMT1 and PRC2. This ensures stable gene expression patterns and is critical for development and tissue homeostasis.
Key Genes Involved in GO:0045892 negative regulation of DNA-templated transcription
The following genes encode key components of negative regulation of DNA-templated transcription, including transcription factors, chromatin modifiers, and co-repressors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIC1 | Sequence-specific transcriptional repressor | Mutations linked to cancer; SNP analysis reveals functional variants |
| HDAC1 | Histone deacetylase | Removes acetyl groups to repress transcription; drug target |
| HDAC2 | Histone deacetylase | Component of co-repressor complexes |
| SIN3A | Scaffold protein for co-repressor complexes | Recruits HDACs to repress target genes |
| NCOR1 | Nuclear receptor co-repressor | Mediates repression by nuclear receptors |
| NCOR2 | Nuclear receptor co-repressor | Similar to NCOR1; involved in chromatin remodeling |
| EZH2 | Histone methyltransferase | Catalyzes H3K27me3 for Polycomb-mediated repression |
| SUV39H1 | Histone methyltransferase | Catalyzes H3K9me3 for heterochromatin formation |
| DNMT1 | DNA methyltransferase | Maintains DNA methylation for stable repression |
| DNMT3A | DNA methyltransferase | De novo DNA methylation |
| DNMT3B | DNA methyltransferase | De novo DNA methylation |
| MECP2 | Methyl-CpG-binding protein | Binds methylated DNA and recruits co-repressors |
| KDM1A | Histone demethylase | Removes repressive marks; can also repress via other mechanisms |
| CTBP1 | Transcriptional co-repressor | Recruits HDACs and other chromatin modifiers |
| CTBP2 | Transcriptional co-repressor | Similar to CTBP1 |
| BCL6 | Sequence-specific repressor | Represses genes involved in B-cell differentiation |
| GATA3 | Transcription factor | Can act as repressor in specific contexts |
How Is negative regulation of DNA-templated transcription Regulated?
Negative regulation of DNA-templated transcription is itself regulated by signaling pathways that modify repressor activity. For example, phosphorylation of repressor proteins can alter their DNA-binding affinity or co-repressor recruitment. Metabolic signals can influence the availability of acetyl-CoA and S-adenosylmethionine, affecting histone acetylation and methylation. Additionally, the ubiquitin-proteasome system controls the stability of repressor complexes.
negative regulation of DNA-templated transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIC1 | Breast cancer, developmental defects | Knockout and point mutation in breast cancer cell lines |
| MECP2 | Rett syndrome | Knock-in mouse models and iPSC-derived neurons |
| HDAC1/2 | Cancer, neurodegeneration | Conditional knockout in mouse models |
| EZH2 | Lymphoma, Weaver syndrome | Point mutation knock-in and overexpression |
| DNMT3A | Acute myeloid leukemia | Knockout and point mutation in hematopoietic stem cells |
Cancer
Dysregulation of transcriptional repression is a hallmark of cancer. Loss-of-function mutations in repressor genes such as HIC1 lead to inappropriate activation of oncogenic pathways. Pathway-level mutational signatures in breast cancer reveal that defects in negative regulation of transcription predict poor outcomes and identify therapeutic targets.
Developmental disorders
Mutations in chromatin modifiers and co-repressors cause developmental syndromes. For example, MECP2 mutations cause Rett syndrome, a neurodevelopmental disorder characterized by loss of transcriptional repression.
Metabolic disease
Transcriptional repression controls metabolic gene programs. Altered histone acetylation and methylation contribute to insulin resistance and obesity.
From negative regulation of DNA-templated transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a repressor activate target genes? | CRISPR knockout in cell lines followed by RNA-seq |
| Does a point mutation in a DNA-binding domain abolish repression? | CRISPR point mutation knock-in |
| Can a repressor be tagged for chromatin immunoprecipitation? | Knock-in of epitope tag (e.g., HA, FLAG) |
| Does overexpression of a repressor silence oncogenes? | CRISPR overexpression (ORF) in cancer cells |
| Which co-repressors are essential for gene silencing? | CRISPR library screening |
| How does a repressor mutation affect chromatin accessibility? | ATAC-seq in knockout cells |
How to Study the negative regulation of DNA-templated transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state mRNA levels | Identify genes derepressed upon repressor knockout |
| ChIP-seq | Protein-DNA binding and histone marks | Map repressor binding sites and chromatin states |
| ATAC-seq | Chromatin accessibility | Assess changes in open chromatin after perturbation |
| CRISPR knockout screen | Gene essentiality and pathway interactions | Discover co-repressors and synthetic lethal targets |
| Reporter assays | Transcriptional activity | Validate repressor function on specific promoters |
| Proteomics | Protein interactions and modifications | Identify co-repressor complex components |
| Single-cell RNA-seq | Cell-to-cell variability | Study repression heterogeneity in tissues |
| Computational SNP analysis | Functional impact of variants | Predict deleterious mutations in repressor genes |
Transcriptomic profiling
RNA-seq measures changes in gene expression upon perturbation of repressor genes. It can identify direct and indirect target genes and reveal global repression networks.
Chromatin immunoprecipitation
ChIP-seq maps genome-wide binding sites of repressor proteins and histone modifications such as H3K27me3 and H3K9me3.
Chromatin accessibility assays
ATAC-seq measures open chromatin regions and can detect changes in accessibility caused by loss of repressors.
CRISPR screens
Pooled CRISPR knockout or activation screens identify genes that regulate transcriptional repression pathways.
How CRISPR Can Be Used to Study GO:0045892 negative regulation of DNA-templated transcription
Knockout
CRISPR knockout of repressor genes such as HIC1 or HDAC1 allows researchers to assess loss-of-function phenotypes, including target gene derepression and changes in cell proliferation.
Point Mutation
Introducing specific point mutations in DNA-binding domains or catalytic residues of repressors can dissect their functional domains without altering protein levels.
Knock-in
Knock-in of epitope tags or fluorescent reporters enables visualization and purification of repressor complexes for biochemical and imaging studies.
Overexpression
CRISPR activation or ORF overexpression can test whether increased repressor levels are sufficient to silence target genes or inhibit tumor growth.
How EDITGENE Supports negative regulation of DNA-templated transcription Research
Researchers studying negative regulation of DNA-templated transcription-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as target gene derepression or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of DNA-templated transcription research.
Frequently Asked Questions About negative regulation of DNA-templated transcription
What is negative regulation of DNA-templated transcription?
It is any process that stops, prevents, or reduces the frequency, rate, or extent of DNA-templated transcription, as defined by GO:0045892.
What genes are involved in negative regulation of DNA-templated transcription?
Key genes include HIC1, HDAC1, HDAC2, SIN3A, NCOR1, EZH2, and DNMT1, among others.
How is negative regulation of DNA-templated transcription studied?
Common methods include RNA-seq, ChIP-seq, ATAC-seq, reporter assays, and CRISPR screens.
What diseases are associated with defects in transcriptional repression?
Cancer, Rett syndrome, and metabolic disorders are linked to dysregulated repression.
What is the role of HIC1 in transcriptional repression?
HIC1 is a sequence-specific repressor that recruits HDAC complexes to silence target genes; mutations are linked to cancer.
How do histone modifications contribute to transcriptional repression?
Histone deacetylation and methylation create repressive chromatin that blocks RNA polymerase access.
Can CRISPR be used to study negative regulation of transcription?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of repressor function.
What is the difference between negative regulation of transcription and gene silencing?
Gene silencing often refers to stable, long-term repression, while negative regulation encompasses any reduction in transcription, including transient effects.
Which signaling pathways regulate transcriptional repressors?
Phosphorylation, acetylation, and ubiquitination modulate repressor activity and stability.
What are the best cell models for studying transcriptional repression?
Cancer cell lines, iPSCs, and primary cells with CRISPR perturbations are widely used.
Conclusion
Negative regulation of DNA-templated transcription (GO:0045892) is a fundamental biological process that controls gene expression programs essential for development and homeostasis. Its dysregulation contributes to cancer and other diseases, making it a critical area of research. CRISPR-based models and multi-omics approaches are powerful tools to dissect repressor networks and identify therapeutic targets.
References
- 1. Posta M et al.. 2025. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets.. Br J Pharmacol 182(23):5734-5747 PMID: 41057034
- 2. Li X et al.. 2021. Integrative Chemical Biology Approaches to Deciphering the Histone Code: A Problem-Driven Journey.. Acc Chem Res 54(19):3734-3747 PMID: 34553920
- 3. Annanya A et al.. 2024. Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene.. Cureus 16(3):e56664 PMID: 38646326
- 4. Jing Y et al.. 2022. Roles of Negatively Charged Histone Lysine Acylations in Regulating Nucleosome Structure and Dynamics.. Front Mol Biosci 9:899013 PMID: 35547393
- 8. Wu X et al.. 2022. The transcriptome profile of RPE cells by the fullerenol against hydrogen peroxide stress.. Front Med (Lausanne) 9:996280 PMID: 36186803
